Last April, the U.S. Food and Drug Administration (FDA) issued a ban on all sales of pelvic surgical mesh products after determining that the manufacturers, Boston Scientific and Coloplast, failed to “demonstrate [a] reasonable assurance of safety and effectiveness.”
On May 14, 25 white male legislators in Alabama decided the fate of reproductive health for millions of women in their state. This astonishingly homogeneous group supported the Human Rights Protection Act [SB 314] 25-6. Although women make up 51 percent of Alabama’s population, only 15 percent of women serve in Alabama’s state legislature. A mere three women were present for the vote.